Biolas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 5,404 | - | - | - | 522,167 | 519,608 | 525,076 | 203,508 |
| Profit before tax | -11,473 | -60 | -64 | -72 | 36,065 | 9,656 | -6,278 | 35,635 |
| Net profit | -11,473 | -60 | -64 | -72 | 30,484 | 8,208 | -6,589 | 35,080 |
| Equity | -9,683 | -9,743 | -9,807 | -9,879 | 20,605 | 28,813 | 15,442 | 50,522 |
| Liabilities | 12,832 | 12,832 | 12,832 | 12,941 | 156,341 | 330,125 | 31,639 | 20,592 |
| Non-current assets | 186 | 186 | 186 | 186 | 186 | 186 | 186 | 186 |
| Current assets | 2,963 | 2,903 | 2,839 | 2,876 | 176,760 | 358,752 | 46,895 | 70,928 |
| Total assets | 3,149 | 3,089 | 3,025 | 3,062 | 176,946 | 358,938 | 47,081 | 71,114 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 8,630 | 5,670 | 776 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -90.5% | - | - | - | - | -0.5% | +1.1% | -61.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -364.3% | -1.9% | -2.1% | -2.4% | 17.2% | 2.3% | -14.0% | 49.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 147.9% | 28.5% | -42.7% | 69.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -212.3% | - | - | - | 5.8% | 1.6% | -1.3% | 17.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -212.3% | - | - | - | 6.9% | 1.9% | -1.2% | 17.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 7.6 | 11.5 | 2.0 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 3,002 | - | - | - | 276,440 | 259,804 | 262,538 | 101,754 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biolas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-11-22 | 2024-11-26 | 55.28 |
| 2024-11-18 | 2024-11-21 | 108.15 |
| 2024-10-16 | 2024-11-17 | 52.87 |
Biolas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-01-10 | 2025-01-15 | 0.62 |
| 2025-01-08 | 2025-01-09 | 188.25 |
| 2025-01-01 | 2025-01-07 | 187.9 |
| 2024-12-25 | 2024-12-31 | 187.63 |
| 2024-12-22 | 2024-12-24 | 235.03 |
| 2024-12-19 | 2024-12-21 | 363.7 |
| 2024-12-03 | 2024-12-18 | 1.6 |
| 2024-11-19 | 2024-11-23 | 2104.58 |
| 2024-11-01 | 2024-11-18 | 2095.04 |
| 2024-10-10 | 2024-10-31 | 3001.14 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biolas, UAB (code 303485444) is a Private Limited Liability Company engaged in non-specialised wholesale trade. In the latest financial year, 2025, the company generated revenue of €203.5K and net profit of €35.1K, corresponding to a profit margin of 17.2%. This marks a clear improvement versus 2024, when the company reported a net loss of €6.6K. In 2023, revenue stood at €519.6K and net profit at €8.2K, so the three-year trajectory shows a materially lower turnover base in 2025, with revenue down 61.2% year on year. Despite the reduced sales level, profitability strengthened significantly in 2025. At year-end 2025, total assets were €71.1K, equity €50.5K and liabilities €20.6K. The balance sheet structure was supported by an equity ratio of 71.0% and a debt-to-equity ratio of 0.41. Asset turnover was 2.86x, while ROE was 69.4% and ROA 49.3%. Revenue per employee reached €101.8K, indicating a productive operating base.